• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ACR

ACRUX LIMITED - Announcements

0.00% ! 1.8¢
Market Cap $7.366M  !

Acrux Limited is an Australia-based specialty pharmaceutical company. The Company is... Acrux Limited is an Australia-based specialty pharmaceutical company. The Company is engaged in developing and commercializing a pipeline of topically applied pharmaceutical products. Its products include Lidocaine and Prilocaine Cream, USP 2.5%/2.5%, Lenzetto, Evamist, Dapsone Gel, 5% and Testosterone Topical Solution, 30 mg / 1.5 ml. Lidocaine and Prilocaine Cream USP (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) is indicated as a topical anesthetic for use on normal intact skin for local analgesia and genital mucous membranes for superficial minor surgery and as pretreatment for infiltration anesthesia. Lenzetto (estradiol 1.53 mg/spray, transdermal spray, solution) is an estradiol spray for women which is used to treat moderate to severe hot flushes commonly associated with menopause. Testosterone Topical Solution is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements



ACR Resignation of Director08/12/16 download Created with Sketch. 252.54KB
ACR Change of Director's Interest Notice18/11/16 download Created with Sketch. 312.97KB
ACR 2016 AGM Results of Meeting10/11/16 download Created with Sketch. 376.48KB
ACR 2016 AGM Script10/11/16 download Created with Sketch. 290.61KB
ACR 2016 AGM Presentation10/11/16 download Created with Sketch. 1.58MB
ACR Change in substantial holding04/11/16 download Created with Sketch. 149.41KB
ACR IPR Petition Filed Against Key Jublia Patent-ACR.AX PRICE SENSITIVE03/11/16 download Created with Sketch. 431.74KB
ACR IPR Petition Filed Against Key Jublia PatentPRICE SENSITIVE03/11/16 download Created with Sketch. 431.74KB
ACR NEW INTELLECTUAL PROPERTY APPLICATION FOR ONYCHOMYCOSIS-ACR.AX PRICE SENSITIVE02/11/16 download Created with Sketch. 256.15KB
ACR Axiron Net Sales, Quarter to September 2016-ACR.AX PRICE SENSITIVE26/10/16 download Created with Sketch. 253.95KB
ACR Change in Company Secretary-ACR.AX 10/10/16 download Created with Sketch. 241.59KB
ACR Acrux 2016 Annual Report-ACR.AX 07/10/16 download Created with Sketch. 7.17MB
ACR Notice of 2016 Annual General Meeting and Proxy Form-ACR.AX 07/10/16 download Created with Sketch. 280.38KB
ACR Change in substantial holding-ACR.AX 30/08/16 download Created with Sketch. 145.73KB
ACR Acrux Financial Report for the year ended 30 June 2016-ACR.AX 28/08/16 download Created with Sketch. 955.18KB
ACR Appendix 4E-ACR.AX PRICE SENSITIVE28/08/16 download Created with Sketch. 223.19KB
ACR Appendix 4G-ACR.AX 28/08/16 download Created with Sketch. 313.05KB
ACR Change in substantial holding-ACR.AX 28/08/16 download Created with Sketch. 152.24KB
ACR Acrux announces 2016 financial results-ACR.AX PRICE SENSITIVE28/08/16 download Created with Sketch. 383.41KB
ACR Change in substantial holding-ACR.AX 25/08/16 download Created with Sketch. 152.24KB
ACR Acrux Financial Report for the year ended 30 June 2016-ACR.AX 25/08/16 download Created with Sketch. 955.18KB
ACR Acrux announces 2016 financial results-ACR.AX PRICE SENSITIVE25/08/16 download Created with Sketch. 383.41KB
ACR Appendix 4G-ACR.AX 25/08/16 download Created with Sketch. 313.05KB
ACR Appendix 4E-ACR.AX PRICE SENSITIVE25/08/16 download Created with Sketch. 223.19KB
ACR Acrux and Eli Lilly to appeal patent ruling on Axiron-ACR.AX PRICE SENSITIVE24/08/16 download Created with Sketch. 366.43KB
ACR Acrux announces court ruling on Axiron patent families-ACR.AX PRICE SENSITIVE23/08/16 download Created with Sketch. 329.42KB
ACR 2016 Annual Results and Investor Conference Call-ACR.AX 22/08/16 download Created with Sketch. 328.02KB
ACR Acrux defers release of 2016 financial results-ACR.AX 08/08/16 download Created with Sketch. 404.59KB
ACR 2016 Annual Results - investor conference call-ACR.AX 04/08/16 download Created with Sketch. 454.08KB
ACR Axiron Net Sales, quarter to June 2016-ACR.AX PRICE SENSITIVE27/07/16 download Created with Sketch. 592.1KB
ACR Acrux generic strategy and Axiron patent litigation update-ACR.AX PRICE SENSITIVE30/06/16 download Created with Sketch. 351.92KB
ACR Appendix 3Y-ACR.AX 10/06/16 download Created with Sketch. 283.73KB
ACR Acrux announces non-executive board appointments-ACR.AX 01/06/16 download Created with Sketch. 343.41KB
ACR Acrux presents at BioTrinity-ACR.AX 27/04/16 download Created with Sketch. 2.12MB
ACR Axiron Net Sales, quarter to March 2016-ACR.AX PRICE SENSITIVE27/04/16 download Created with Sketch. 499KB
ACR S&P DJ Indices Announces March Quarterly Review11/03/16 download Created with Sketch. 337.28KB
ACR Acrux half-year financial report - December 201525/02/16 download Created with Sketch. 1.16MB
ACR Acrux Appendix 4D - December 2015PRICE SENSITIVE25/02/16 download Created with Sketch. 173.96KB
ACR Axiron Net Sales, quarter to 31 December 2015PRICE SENSITIVE29/01/16 download Created with Sketch. 423.24KB
ACR Launch of Lenzetto28/01/16 download Created with Sketch. 341.09KB
ACR Appendix 3B27/01/16 download Created with Sketch. 3.64MB
ACR Half-Year Investor Conference Call25/01/16 download Created with Sketch. 348.81KB
ACR 2015 AGM Results of Meeting17/11/15 download Created with Sketch. 59.44KB
ACR 2015 AGM Presentation and Script17/11/15 download Created with Sketch. 3.01MB
ACR Axiron Net Sales, quarter to September 2015PRICE SENSITIVE23/10/15 download Created with Sketch. 357.36KB
ACR Notice of 2015 Annual Genral Meeting, Proxy Form and ESOP15/10/15 download Created with Sketch. 659.28KB
ACR Acrux 2015 Annual Report15/10/15 download Created with Sketch. 1.83MB
ACR Notice of 2015 Annual General Meeting and Proxy Form15/10/15 download Created with Sketch. 566.07KB
ACR Acrux presents at AusBiotech Invest08/10/15 download Created with Sketch. 1.11MB
ACR European approvals and milestone payments for LenzettoPRICE SENSITIVE07/09/15 download Created with Sketch. 124.8KB
ACR Investor Presentation 20 August 201520/08/15 download Created with Sketch. 1.41MB
ACR Ceasing to be a substantial holder14/08/15 download Created with Sketch. 69.47KB
ACR Dividend/Distribution - ACR13/08/15 download Created with Sketch. 30.79KB
ACR Acrux announces 2015 Financial Result and DividendPRICE SENSITIVE13/08/15 download Created with Sketch. 1.98MB
ACR Full Year Results Investor Conference Call12/08/15 download Created with Sketch. 364.51KB
ACR Change in substantial holding12/08/15 download Created with Sketch. 232.57KB
ACR Change in substantial holding07/08/15 download Created with Sketch. 218.17KB
ACR Change in substantial holding05/08/15 download Created with Sketch. 839.82KB
ACR Issue of Options04/08/15 download Created with Sketch. 4.43MB
ACR Ceasing to be a substantial holder29/07/15 download Created with Sketch. 803.99KB
ACR Axiron Net Sales, quarter to June 2015PRICE SENSITIVE24/07/15 download Created with Sketch. 407.51KB
ACR Appointment of leadership positions13/07/15 download Created with Sketch. 354.97KB
ACR Lilly and Acrux file lawsuit against LupinPRICE SENSITIVE07/07/15 download Created with Sketch. 356.15KB
ACR Axiron Net Sales, quarter to March 2015PRICE SENSITIVE24/04/15 download Created with Sketch. 103.98KB
ACR Change in substantial holding10/03/15 download Created with Sketch. 126.57KB
ACR Call on the FDA Drug Safety Communication04/03/15 download Created with Sketch. 230.52KB
ACR FDA Testosterone update04/03/15 download Created with Sketch. 175.42KB
ACR Director Resignation26/02/15 download Created with Sketch. 248.21KB
ACR Half-Year Results Presentation - 31 December 201426/02/15 download Created with Sketch. 1.06MB
ACR Half-Year Financial Report26/02/15 download Created with Sketch. 5.67MB
ACR Appendix 4D - 31 December 2014PRICE SENSITIVE26/02/15 download Created with Sketch. 163.9KB
ACR Half-year earnings call for the period ended 31 Dec 201423/02/15 download Created with Sketch. 229.55KB
ACR Ceasing to be a substantial holder13/02/15 download Created with Sketch. 134.87KB
ACR Change in substantial holding06/02/15 download Created with Sketch. 157.57KB
ACR 2015 EGM Results of Meeting03/02/15 download Created with Sketch. 290.2KB
ACR 2015 EGM Chairman's Address and Presentation03/02/15 download Created with Sketch. 274.01KB
ACR Axiron Net Sales, quarter to 31 December 2014PRICE SENSITIVE02/02/15 download Created with Sketch. 231.85KB
ACR Change in substantial holding30/01/15 download Created with Sketch. 369.1KB
ACR Change in substantial holding21/01/15 download Created with Sketch. 358.54KB
ACR Change in substantial holding07/01/15 download Created with Sketch. 420.87KB
ACR Notice of Extraordinary General Meeting and Proxy Form23/12/14 download Created with Sketch. 2.37MB
ACR Lilly and Acrux file lawsuit against AmnealPRICE SENSITIVE11/12/14 download Created with Sketch. 110.06KB
ACR Becoming a substantial holder03/12/14 download Created with Sketch. 800.96KB
ACR 2014 AGM Results of Meeting27/11/14 download Created with Sketch. 310.08KB
ACR 2014 AGM Chariman's Address and Presentation27/11/14 download Created with Sketch. 807.08KB
ACR Change in substantial holding26/11/14 download Created with Sketch. 509.23KB
ACR European Medicines Agency Testosterone update24/11/14 download Created with Sketch. 2.97MB
ACR Investor Presentation12/11/14 download Created with Sketch. 4.65MB
ACR 2014 Annual Report24/10/14 download Created with Sketch. 4.35MB
ACR Notice of Annual General Meeting and Proxy Form24/10/14 download Created with Sketch. 2.7MB
ACR Axiron Net Sales, quarter to 30 September 2014PRICE SENSITIVE24/10/14 download Created with Sketch. 106.54KB
ACR +Ceasing to be a substantial holder from AMP21/10/14 download Created with Sketch. 378.88KB
ACR Change in substantial holding15/10/14 download Created with Sketch. 336.53KB
ACR Change in substantial holding14/10/14 download Created with Sketch. 335.27KB
ACR +Change in substantial holding from AMP13/10/14 download Created with Sketch. 392.17KB
ACR Change in substantial holding13/10/14 download Created with Sketch. 744.71KB
ACR Company Secretary Change24/09/14 download Created with Sketch. 104.04KB
ACR Response to ASX Price QueryPRICE SENSITIVE18/09/14 download Created with Sketch. 285.25KB
ACR FDA Advisory Committee Meeting on TRT18/09/14 download Created with Sketch. 23.47KB
ACR Trading HaltPRICE SENSITIVE18/09/14 download Created with Sketch. 29.93KB
ACR Resignation of Director
08/12/16 download Created with Sketch. 252.54KB
ACR Change of Director's Interest Notice
18/11/16 download Created with Sketch. 312.97KB
ACR 2016 AGM Results of Meeting
10/11/16 download Created with Sketch. 376.48KB
ACR 2016 AGM Script
10/11/16 download Created with Sketch. 290.61KB
ACR 2016 AGM Presentation
10/11/16 download Created with Sketch. 1.58MB
ACR Change in substantial holding
04/11/16 download Created with Sketch. 149.41KB
ACR IPR Petition Filed Against Key Jublia Patent-ACR.AX
03/11/16PRICE SENSITIVE download Created with Sketch. 431.74KB
ACR IPR Petition Filed Against Key Jublia Patent
03/11/16PRICE SENSITIVE download Created with Sketch. 431.74KB
ACR NEW INTELLECTUAL PROPERTY APPLICATION FOR ONYCHOMYCOSIS-ACR.AX
02/11/16PRICE SENSITIVE download Created with Sketch. 256.15KB
ACR Axiron Net Sales, Quarter to September 2016-ACR.AX
26/10/16PRICE SENSITIVE download Created with Sketch. 253.95KB
ACR Change in Company Secretary-ACR.AX
10/10/16 download Created with Sketch. 241.59KB
ACR Acrux 2016 Annual Report-ACR.AX
07/10/16 download Created with Sketch. 7.17MB
ACR Notice of 2016 Annual General Meeting and Proxy Form-ACR.AX
07/10/16 download Created with Sketch. 280.38KB
ACR Change in substantial holding-ACR.AX
30/08/16 download Created with Sketch. 145.73KB
ACR Acrux Financial Report for the year ended 30 June 2016-ACR.AX
28/08/16 download Created with Sketch. 955.18KB
ACR Appendix 4E-ACR.AX
28/08/16PRICE SENSITIVE download Created with Sketch. 223.19KB
ACR Appendix 4G-ACR.AX
28/08/16 download Created with Sketch. 313.05KB
ACR Change in substantial holding-ACR.AX
28/08/16 download Created with Sketch. 152.24KB
ACR Acrux announces 2016 financial results-ACR.AX
28/08/16PRICE SENSITIVE download Created with Sketch. 383.41KB
ACR Change in substantial holding-ACR.AX
25/08/16 download Created with Sketch. 152.24KB
ACR Acrux Financial Report for the year ended 30 June 2016-ACR.AX
25/08/16 download Created with Sketch. 955.18KB
ACR Acrux announces 2016 financial results-ACR.AX
25/08/16PRICE SENSITIVE download Created with Sketch. 383.41KB
ACR Appendix 4G-ACR.AX
25/08/16 download Created with Sketch. 313.05KB
ACR Appendix 4E-ACR.AX
25/08/16PRICE SENSITIVE download Created with Sketch. 223.19KB
ACR Acrux and Eli Lilly to appeal patent ruling on Axiron-ACR.AX
24/08/16PRICE SENSITIVE download Created with Sketch. 366.43KB
ACR Acrux announces court ruling on Axiron patent families-ACR.AX
23/08/16PRICE SENSITIVE download Created with Sketch. 329.42KB
ACR 2016 Annual Results and Investor Conference Call-ACR.AX
22/08/16 download Created with Sketch. 328.02KB
ACR Acrux defers release of 2016 financial results-ACR.AX
08/08/16 download Created with Sketch. 404.59KB
ACR 2016 Annual Results - investor conference call-ACR.AX
04/08/16 download Created with Sketch. 454.08KB
ACR Axiron Net Sales, quarter to June 2016-ACR.AX
27/07/16PRICE SENSITIVE download Created with Sketch. 592.1KB
ACR Acrux generic strategy and Axiron patent litigation update-ACR.AX
30/06/16PRICE SENSITIVE download Created with Sketch. 351.92KB
ACR Appendix 3Y-ACR.AX
10/06/16 download Created with Sketch. 283.73KB
ACR Acrux announces non-executive board appointments-ACR.AX
01/06/16 download Created with Sketch. 343.41KB
ACR Acrux presents at BioTrinity-ACR.AX
27/04/16 download Created with Sketch. 2.12MB
ACR Axiron Net Sales, quarter to March 2016-ACR.AX
27/04/16PRICE SENSITIVE download Created with Sketch. 499KB
ACR S&P DJ Indices Announces March Quarterly Review
11/03/16 download Created with Sketch. 337.28KB
ACR Acrux half-year financial report - December 2015
25/02/16 download Created with Sketch. 1.16MB
ACR Acrux Appendix 4D - December 2015
25/02/16PRICE SENSITIVE download Created with Sketch. 173.96KB
ACR Axiron Net Sales, quarter to 31 December 2015
29/01/16PRICE SENSITIVE download Created with Sketch. 423.24KB
ACR Launch of Lenzetto
28/01/16 download Created with Sketch. 341.09KB
ACR Appendix 3B
27/01/16 download Created with Sketch. 3.64MB
ACR Half-Year Investor Conference Call
25/01/16 download Created with Sketch. 348.81KB
ACR 2015 AGM Results of Meeting
17/11/15 download Created with Sketch. 59.44KB
ACR 2015 AGM Presentation and Script
17/11/15 download Created with Sketch. 3.01MB
ACR Axiron Net Sales, quarter to September 2015
23/10/15PRICE SENSITIVE download Created with Sketch. 357.36KB
ACR Notice of 2015 Annual Genral Meeting, Proxy Form and ESOP
15/10/15 download Created with Sketch. 659.28KB
ACR Acrux 2015 Annual Report
15/10/15 download Created with Sketch. 1.83MB
ACR Notice of 2015 Annual General Meeting and Proxy Form
15/10/15 download Created with Sketch. 566.07KB
ACR Acrux presents at AusBiotech Invest
08/10/15 download Created with Sketch. 1.11MB
ACR European approvals and milestone payments for Lenzetto
07/09/15PRICE SENSITIVE download Created with Sketch. 124.8KB
ACR Investor Presentation 20 August 2015
20/08/15 download Created with Sketch. 1.41MB
ACR Ceasing to be a substantial holder
14/08/15 download Created with Sketch. 69.47KB
ACR Dividend/Distribution - ACR
13/08/15 download Created with Sketch. 30.79KB
ACR Acrux announces 2015 Financial Result and Dividend
13/08/15PRICE SENSITIVE download Created with Sketch. 1.98MB
ACR Full Year Results Investor Conference Call
12/08/15 download Created with Sketch. 364.51KB
ACR Change in substantial holding
12/08/15 download Created with Sketch. 232.57KB
ACR Change in substantial holding
07/08/15 download Created with Sketch. 218.17KB
ACR Change in substantial holding
05/08/15 download Created with Sketch. 839.82KB
ACR Issue of Options
04/08/15 download Created with Sketch. 4.43MB
ACR Ceasing to be a substantial holder
29/07/15 download Created with Sketch. 803.99KB
ACR Axiron Net Sales, quarter to June 2015
24/07/15PRICE SENSITIVE download Created with Sketch. 407.51KB
ACR Appointment of leadership positions
13/07/15 download Created with Sketch. 354.97KB
ACR Lilly and Acrux file lawsuit against Lupin
07/07/15PRICE SENSITIVE download Created with Sketch. 356.15KB
ACR Axiron Net Sales, quarter to March 2015
24/04/15PRICE SENSITIVE download Created with Sketch. 103.98KB
ACR Change in substantial holding
10/03/15 download Created with Sketch. 126.57KB
ACR Call on the FDA Drug Safety Communication
04/03/15 download Created with Sketch. 230.52KB
ACR FDA Testosterone update
04/03/15 download Created with Sketch. 175.42KB
ACR Director Resignation
26/02/15 download Created with Sketch. 248.21KB
ACR Half-Year Results Presentation - 31 December 2014
26/02/15 download Created with Sketch. 1.06MB
ACR Half-Year Financial Report
26/02/15 download Created with Sketch. 5.67MB
ACR Appendix 4D - 31 December 2014
26/02/15PRICE SENSITIVE download Created with Sketch. 163.9KB
ACR Half-year earnings call for the period ended 31 Dec 2014
23/02/15 download Created with Sketch. 229.55KB
ACR Ceasing to be a substantial holder
13/02/15 download Created with Sketch. 134.87KB
ACR Change in substantial holding
06/02/15 download Created with Sketch. 157.57KB
ACR 2015 EGM Results of Meeting
03/02/15 download Created with Sketch. 290.2KB
ACR 2015 EGM Chairman's Address and Presentation
03/02/15 download Created with Sketch. 274.01KB
ACR Axiron Net Sales, quarter to 31 December 2014
02/02/15PRICE SENSITIVE download Created with Sketch. 231.85KB
ACR Change in substantial holding
30/01/15 download Created with Sketch. 369.1KB
ACR Change in substantial holding
21/01/15 download Created with Sketch. 358.54KB
ACR Change in substantial holding
07/01/15 download Created with Sketch. 420.87KB
ACR Notice of Extraordinary General Meeting and Proxy Form
23/12/14 download Created with Sketch. 2.37MB
ACR Lilly and Acrux file lawsuit against Amneal
11/12/14PRICE SENSITIVE download Created with Sketch. 110.06KB
ACR Becoming a substantial holder
03/12/14 download Created with Sketch. 800.96KB
ACR 2014 AGM Results of Meeting
27/11/14 download Created with Sketch. 310.08KB
ACR 2014 AGM Chariman's Address and Presentation
27/11/14 download Created with Sketch. 807.08KB
ACR Change in substantial holding
26/11/14 download Created with Sketch. 509.23KB
ACR European Medicines Agency Testosterone update
24/11/14 download Created with Sketch. 2.97MB
ACR Investor Presentation
12/11/14 download Created with Sketch. 4.65MB
ACR 2014 Annual Report
24/10/14 download Created with Sketch. 4.35MB
ACR Notice of Annual General Meeting and Proxy Form
24/10/14 download Created with Sketch. 2.7MB
ACR Axiron Net Sales, quarter to 30 September 2014
24/10/14PRICE SENSITIVE download Created with Sketch. 106.54KB
ACR +Ceasing to be a substantial holder from AMP
21/10/14 download Created with Sketch. 378.88KB
ACR Change in substantial holding
15/10/14 download Created with Sketch. 336.53KB
ACR Change in substantial holding
14/10/14 download Created with Sketch. 335.27KB
ACR +Change in substantial holding from AMP
13/10/14 download Created with Sketch. 392.17KB
ACR Change in substantial holding
13/10/14 download Created with Sketch. 744.71KB
ACR Company Secretary Change
24/09/14 download Created with Sketch. 104.04KB
ACR Response to ASX Price Query
18/09/14PRICE SENSITIVE download Created with Sketch. 285.25KB
ACR FDA Advisory Committee Meeting on TRT
18/09/14 download Created with Sketch. 23.47KB
ACR Trading Halt
18/09/14PRICE SENSITIVE download Created with Sketch. 29.93KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
1.8¢
Change
0.000(0.00%)
Mkt cap ! $7.366M
Open High Low Value Volume
1.8¢ 1.8¢ 1.8¢ $5.04K 280K

Buyers (Bids)

No. Vol. Price($)
6 916823 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.9¢ 265520 1
View Market Depth
Last trade - 14.14pm 29/07/2025 (20 minute delay) ?
Last
1.8¢
  Change
0.000 ( 5.26 %)
Open High Low Volume
1.8¢ 1.8¢ 1.8¢ 53130
Last updated 11.05am 29/07/2025 ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.